NMTC
NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation (NMTC) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 29.3 (oversold), with 0/3 trend checks passing.
NMTC with MA50 and MA200
Key levels & signals
NeuroOne Medical Technologies Corporation (NMTC) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $2.51, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 29.6% and below the 200-day moving average by 43.1%.
NMTC currently has an RSI reading of 29.3, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.
For traders reviewing NMTC next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.
About NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
NMTC shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about NMTC
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.